Dai JY - Search Results

1

Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.

Wu YS, Bao DK, Dai JY, Chen C, Zhang HX, Yang Y, Xing JL, Huang XJ, Wan SG. Wu YS, et al. Among authors: dai jy. Asian Pac J Cancer Prev. 2015;16(3):1051-6. doi: 10.7314/apjcp.2015.16.3.1051. Asian Pac J Cancer Prev. 2015. PMID: 25735330 Free article.

2

Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.

Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, Jiang JL, Zhang SH, Chen ZN. Zhao P, et al. Among authors: dai jy. Cancer Sci. 2010 Feb;101(2):387-95. doi: 10.1111/j.1349-7006.2009.01420.x. Epub 2009 Nov 2. Cancer Sci. 2010. PMID: 20047591 Free PMC article.

3

Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection.

Dai J, Wan S, Zhou F, Myers RE, Guo X, Li B, Fu X, Palazzo JP, Dou K, Yang H, Xing J. Dai J, et al. PLoS One. 2012;7(4):e34758. doi: 10.1371/journal.pone.0034758. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496856 Free PMC article.

4

Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.

Zhang H, Guo X, Dai J, Wu Y, Ge N, Yang Y, Ji J, Zhang H. Zhang H, et al. Med Oncol. 2014 Nov;31(11):278. doi: 10.1007/s12032-014-0278-z. Epub 2014 Oct 22. Med Oncol. 2014. PMID: 25355558

5

Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.

Jiang H, Dai J, Huang X, Chen Y, Qu P, Li J, Yi C, Yang Y, Zhang K, Huang Q. Jiang H, et al. Sci Rep. 2015 Mar 26;5:9536. doi: 10.1038/srep09536. Sci Rep. 2015. PMID: 25826294 Free PMC article.

6

Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.

Xie S, Zhou F, Wang J, Cao H, Chen Y, Liu X, Zhang Z, Dai J, He X. Xie S, et al. World J Surg Oncol. 2015 Feb 12;13:42. doi: 10.1186/s12957-015-0440-x. World J Surg Oncol. 2015. PMID: 25890184 Free PMC article.

7

Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma.

Dai J, Huang Q, Niu K, Wang B, Li Y, Dai C, Chen Z, Tao K, Dai J. Dai J, et al. Cancer Med. 2018 Nov;7(11):5691-5703. doi: 10.1002/cam4.1826. Epub 2018 Oct 11. Cancer Med. 2018. PMID: 30311444 Free PMC article.

8

The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.

Dai JY, Dou KF, Wang CH, Zhao P, Lau WB, Tao L, Wu YM, Tang J, Jiang JL, Chen ZN. Dai JY, et al. BMC Cancer. 2009 Sep 23;9:337. doi: 10.1186/1471-2407-9-337. BMC Cancer. 2009. PMID: 19775453 Free PMC article.

9

[Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells].

Dai J, Niu K, Wang B, Li Y, Xia C, Tao K, Dai J. Dai J, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 May;34(5):427-433. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018. PMID: 30043734 Chinese.

10

Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.

Yang X, Dai J, Li T, Zhang P, Ma Q, Li Y, Zhou J, Lei D. Yang X, et al. Oral Oncol. 2010 Oct;46(10):755-60. doi: 10.1016/j.oraloncology.2010.08.008. Epub 2010 Sep 17. Oral Oncol. 2010. PMID: 20850374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters